"Woman," "elderly," and "disabled" were among a list of banned words reportedly circulating within the FDA, which the White ...

Leaders at the Fred Hutch Cancer Center said the Trump administration's proposed NIH funding cuts would be "chilling, ...

Last year was one of the most productive in the history of the Allen Institute for Artificial Intelligence (Ai2). Next up: translating all that work into real-world solutions.

Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to everyone.

If you believe that biomedical research is good for our state and our country, contact your elected representatives and ask them to reverse the NIH cuts. Talk to your friends and family. Let them know ...

Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...

Hundreds of people demonstrated against a new National Institute of Health directive that would carve a massive hole in ...

Seattle's Fred Hutch Cancer Center to invest $13.5 million in cybersecurity upgrades following 2023 data breach settlement. Class members may receive up to $5K.

Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...

Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

There are many large language models to choose from; some excel at coding, whereas others are better for synthesizing ...

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...